Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy Subjects
This research study is investigating a new medication called GH001. We're testing a special inhaler designed to deliver this medicine. The main goal is to understand how GH001 moves through the body, how quickly it works, and how it’s broken down. We also want to check if it’s safe and well-tolerated by healthy volunteers. We will be looking for any side effects and how people feel after taking it, including any changes to their mood or thinking. This is an early-stage study, meaning it’s one of the first times this specific delivery method for GH001 is being tested in people. Understanding these basic things is crucial before it can be studied in people with specific health conditions.
At a glance
What is this study about?
This study is about a new way of giving a medicine called GH001 using a special inhaler. Think of it like a new type of asthma inhaler, but for a different kind of medicine. We want to understand how this medicine works inside healthy people's bodies. This includes how much of it gets into the bloodstream, how quickly it starts to work, and how long it stays in the body before it's gone. We'll also be carefully checking for any side effects to make sure it's safe to use.
Because this is an early study, we're testing it in healthy volunteers (people who don't have known health problems). This helps us get a clear picture of how the medicine acts in the body without other illnesses complicating things. We'll give the medicine as a single dose and also try a special dosing plan tailored to each person.
Beyond just tracking the medicine, we'll also be seeing if GH001 causes any changes in mood or how people think, and how their breathing is affected. This helps us understand all the different ways the medicine might affect someone. All of this information is really important because it helps scientists decide if GH001 shows promise for future studies in people who might actually benefit from it.
Key takeaways
- This study is testing a new inhaled medicine called GH001.
- It aims to understand how the medicine behaves in the body and if it's safe for healthy people.
- It's a 'Phase 1' study, which means it's an early safety and dosage trial.
- Researchers will also look at how GH001 affects mood and thinking.
- Your participation helps advance medical science, even if there's no direct personal health benefit.
Who may be eligible?
To join this study, you need to be a healthy volunteer between 18 and 64 years old. We'll check your general health, including your lung function with a simple breathing test, and make sure you're physically and mentally well.
There are some reasons why you might not be able to join. For example, if you have allergies to certain similar medicines like melatonin or other 'triptans', you won't be able to take part. Also, if you've been in another research study or taken an experimental medicine in the last three months, you wouldn't be eligible.
Finally, if you have any serious health problems now or in the past that the study doctor thinks would make it unsafe for you to participate, then this study might not be right for you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you between 18 and 64 years old?
- Do you feel generally healthy, both physically and mentally?
- Do you have good lung function (we'll check this)?
- Have you avoided other research studies or experimental medicines in the last 3 months?
- Do you have any known allergies to medicines like melatonin or other 'triptans' (if so, you can't join)?
What does participation involve?
If you decide to take part, you'll visit the study clinic for various assessments. This includes health checks, blood tests, and breathing tests. You'll use the special inhaler to take the study medicine, GH001, either as a single dose or following a specific plan for one day. Researchers will then closely monitor you for a period to see how the medicine affects you, checking for any side effects and taking more blood samples. The full duration of your involvement, including all visits and follow-up, will be explained to you in detail by the study team.
Potential risks and benefits
Locations (1)
- GH Research Clinical Trial SiteVerified postcodeLondon, United Kingdom· Recruiting
Common questions
What is GH001?
GH001 is a new medicine being tested in this study. We are trying to understand how it works in the body.
What is an 'aerosol delivery device'?
It's like an inhaler used to breathe the medicine directly into your lungs, similar to how some asthma medicines are taken.
Why are you only studying healthy people?
By studying healthy people first, we can clearly see how the medicine acts in the body without other health problems affecting the results. This helps us learn about its basic effects and safety.
Will taking part in the study improve my health?
This study is primarily for research and may not offer direct personal health benefits. Your participation, however, helps scientists learn more about new medicines.
What does 'Phase 1' mean?
Phase 1 means this is one of the very first studies of this medicine in humans. It focuses mainly on safety and how the medicine moves through the body.
How to find out more
GH Research Limited Clinical Trial Enquiries
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.